Eric Sievers - Feb 15, 2024 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Medical Officer
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Eric Sievers
Stock symbol
BCAB
Transactions as of
Feb 15, 2024
Transactions value $
$0
Form type
4
Date filed
2/20/2024, 04:20 PM
Previous filing
Feb 1, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Award $0 +122K +136.21% $0.00 212K Feb 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on February 15, 2025, and the remainder in equal quarterly installments over the three years thereafter, subject to the reporting person's continued service through the applicable vesting date.